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Summary 
Revealing the complex interaction between trans- and cis-regulatory elements and 
identifying these potential binding sites are fundamental problems in understanding gene 
expression. The progresses in ChIP-chip technology facilitate identifying DNA sequences 
that are recognized by a specific transcription factor. However, protein-DNA binding is a 
necessary, but not sufficient, condition for transcription regulation. We need to 
demonstrate that their gene expression levels are correlated to further confirm regulatory 
relationship. Here, instead of using a linear correlation coefficient, we used a non-linear 
function that seems to better capture possible regulatory relationships. By analyzing 
tissue-specific gene expression profiles of human and mouse, we delineate a list of pairs 
of transcription factor and gene with highly correlated expression levels, which may have 
regulatory relationships. Using two closely-related species (human and mouse), we 
perform comparative genome analysis to cross-validate the quality of our prediction. Our 
findings are confirmed by matching publicly available TFBS databases (like TRANFAC 
and ConSite) and by reviewing biological literature. For example, according to our 
analysis, 80% and 85.71% of the targets genes associated with E2F5 and RELB 
transcription factors have the corresponding known binding sites. We also substantiated 
our results on some oncogenes with the biomedical literature. Moreover, we performed 
further analysis on them and found that BCR  and DEK may be regulated by some 
common transcription factors. Similar results for BTG1, FCGR2B and LCK genes were 
also reported. 
1 Introduction 
The completion of the Human Genome Project (HGP) [1-3] signifies not the end of a journey 
but rather the beginning of an exciting expedition in revealing the secret of the human 
genome. To be truly benefited from the HGP, we still need to decipher the biological 
connotation of the sequences; otherwise, these are just some long strings of meaningless 
letters. The natural next step is to identify the functional elements in the human genome and 
understand how the genes regulate and interact with each other. While a large number of 
human genes have been identified, their regulatory mechanism remains mostly unknown even 
at the transcriptional level[4]. 
The main mechanism of transcriptional control is to bind transcription factors (TF) to cis-
elements (TFBS a.k.a. transcription factor binding sites) either upstream or downstream of the 
regulated gene, scattered all along thousands of base pairs in both intergenic and intragenic 
regions. In doing so, it either enhances or suppresses gene transcription. To some extent, 
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trans-elements can be viewed as “keys” needed to unlock the cis-elements which act as 
“locks”. To comprehend gene transcription mechanism, it is not sufficient to know which 
keys (trans-elements) are needed to lock/unlock a specific gene, but we also need to identify 
their corresponding locks (cis-elements).  Moreover, identification of binding sites serves as a 
form of validation on the putative trans-elements. If we are able to identify a putative cis-
element, say a conserved sequence element, which is over-represented in the genes that we 
believe to be regulated by a particular transcription factor then it is more plausible that the TF 
acts as a trans-element.  
In silico discovery [5] of binding sites is quite effective for prokaryotes, like Escherichia coli 
[6, 7], where genomes are more compact with many genes being regulated by a single 
operator that is relatively easy to locate. Similar successes have been reported for simple 
unicellular eukaryotes, like Saccharomyces cerevisiae [8-10]. The main approach for finding  
regulatory elements of such simple organisms is to search for overrepresented motifs modeled 
by known background profiles, such as position weighted matrices (PWMs) [11-17], position 
specific score matrices (PSSMs) [11, 18, 19], while some use clustering to demarcate cis-
regulatory modules[20, 21]. For higher multi-cellular eukaryotes, model-based approaches [4, 
22-24] that discover patterns among co-expressed genes with respect to regulating 
transcription factors, have been proposed. The idea behind these techniques involves the 
proximity of common cis-regulatory modules among the co-expressed genes. Among other 
common model-based (a.k.a. machine learning) techniques, artificial neural networks [25], 
greedy algorithm [12], Gibbs Sampling [26], Markov chains [27, 28], Expectation 
Maximization (EM) algorithm [29] are widely used  for eukaryotes. However, it has been 
reported that these model-prediction techniques are susceptible to high false positive 
prediction rate and majority of predicted TFBS generated with predictive models (in silico) 
have no functional role in vivo [14].  
To overcome this potential shortcoming, quite a number of algorithms have been presented 
motivated by “phylogenetic footprinting” [30-33], which is based on searching for similarity 
in sequences due to selective pressure during evolution,. In fact, phylogenetic footprinting 
complements the computational approaches, as sequence conservation across lineage reveals 
segments in genes that might delineate common biological functions. So, to identify 
regulatory regions, orthologous genes at the sequence level are compared. The underlying 
hypothesis that inspires phylogeny as a powerful scheme is that sequences related to vital 
biological functions will be retained under evolutionary selective pressure [34, 35]. It is 
assumed that the orthologous genes are accountable to the same regulatory mechanisms in 
different species. Again, phylogenetic footprinting algorithms can detect putative binding 
sites if it meets two criteria: (1) sequences from organisms with adequate evolutionary 
distance share the same conserved regions, and (2) TFBS are over-represented in the 
proximity. Thus novel methods using cross-species genome comparison can significantly 
improve the overall specificity of predictions [36, 37]. 
Jin et al. [38, 39] analyzed conserved human-mouse orthologous gene pairs to find core 
promoter elements and Bussemaker et al. [23] addressed the issue of detecting regulatory 
elements using correlation of expressions. A recent paper by Kim et al. [40] dealt with 
predicting transcriptional regulatory elements of human promoters using gene expression and 
promoter analysis data, which compare two pools of genes using z-scores. Our aim here is to 
find both trans- and cis-elements in the human genome. Further, to ensure better quality of 
our analysis, we also used mouse tissue-specific gene expression profile and the observation 
that functional elements tend to be conserved between mouse and human. 
As a model organism to compare with, the choice of mouse is obvious [31]. Human and 
mouse have about 25,000 genes each, of which about eighty percent coincide in DNA 
sequence abstraction [41]. Along with progress in sequencing and annotations of mouse Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
genome [42, 43], genome-scale interspecies comparison techniques have evolved [44], and 
geneticists have been amazed by the incredible resemblance between human and mouse 
genomes. In numbers, almost 40% of total nucleotides show exact matches in global 
alignments [45], and about 93.2% of identical nucleotides has been observed in conserved 
regions [46]. Moreover, the mouse-model is extensively used to study the molecular 
foundation and therapy of certain diseases, as functionally related genes are preferentially 
retained in conserved regions [47].  
Based on the flavor of the both strategies of phylogenetic footprinting and co-regulated gene 
expression profiles, in this paper we propose a systematic approach to identify putative 
transcriptional regulatory elements in both human and mouse genomes. Our algorithm 
delineates potential TF-gene pairs by analyzing tissue-specific gene expression data of both 
human and mouse. As a means of validation, we restrict our attention to orthologous TFs and 
genes that share a common gene symbol between the two species, and validate our findings 
by comparing against a widely used TFBS profile registry and reviewed literature.  
To investigate the efficacy of our technique and utility of our findings, we computed the 
correlation among TFs and well-recognized oncogenes to analyze their regulation pattern 
collectively. The objective here is to identify a small collection of common TFs that regulate a 
group of oncogenes. For instance, we observed that leukemia proto-oncogenes like BCR and 
DEK may be regulated sharing some common transcription factors. We also have similar 
results for the genes BTG1, FCGR2B and  LCK. These results together with current 
biomedical literatures serve to corroborate our findings. Additionally, we also clustered the 
oncogenes based on their correlation with TFs and the results we report here support our 
earlier analysis. 
2 Methods 
2.1 Data  preprocessing 
As mentioned earlier, we analyzed expression data for both human and mouse to shortlist co-
expressed genes with respect to TF. We collected microarray data of normal human 
tissues[48], which provide us with 26,260 unique genes from 35 different organs. In total, the 
data set consists of 115 tissue specimens. The tissue samples were obtained from esophagus, 
lungs, cervix, fallopian tube, breast, ovary, uterus, seminal vesicles, prostate, salivary glands, 
thyroids, parathyroid, testes, brain, adrenal, heart, stomach, colon, bowel, kidney, liver, 
lymph, tonsil, spleen, buffy coat, thymus, vagina, skeletal muscle, fallopian tube, uterus and 
gall bladder. For each experimental tissue sample, Cy5- and Cy3- labeled samples were co-
hybridized to a cDNA microarray containing 39,711 human cDNA’s, representing 26,260 
different gene. Expression ratios were globally normalized by mean-centering each gene 
across all arrays.  
Raw microarray expression data for mouse was obtained from [49]. The dataset contains 
expressions of 41,699 known and predicted mRNAs in 55 tissues. The samples include 
adrenal, aorta, bladder, bone marrow, brain, brown fat, calvaria cerebellum, colon, cortex, 
embryo, epididymus, eye, femur, heart, hindbrain, kidney, knee, large intestine, liver, lung, 
lymph node, mammary gland, mandible, midbrain, olfactory bulb, ovary, pancreas, placenta, 
prostate, salivary, skeletal muscle, skin, small intestine, snout, spinal cord, spleen, stomach, 
striatum, teeth, testis, thymus, thyroid, tongue, tongue surface, trachea, trigeminus, uterus etc. 
As the expression annotations were given for NCBI XM sequences, we had to map those to 
official NCBI gene[50] annotation. Although the NCBI repository is being updated and 
adapted, the RefSeq[51] accession number (e.g. XM_213390) may remain unchanged over 
time. Therefore, direct one-to-one correspondence of gene id and accession number does not Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
produce correct gene list. To circumvent this problem, we retrieved the GI (gi) numbers 
(GenInfo Identifier), which are exclusively assigned to the sequence records. This number 
also provides a unique identifier to the sequences, and it is not reused across different versions 
of accession numbers. 
Figure 1: Illustration for TF-gene regulation pattern. Here, the expression data are plotted for 
TF (RELB) along x-axis, and for gene (ATP2B1) along y-axis. Linear regression (straight line) is 
unable to capture majority of points, while the non-linear function curve seems to cover most of 
them. 
Figure 2: Illustration for negatively correlated TF-gene regulation pattern. Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
2.2  Calculation of correlation coefficient 
If a transcription factor does regulate a gene, according to reported results [12, 24] in the 
literature, it is expected that they are linearly correlated. However, we observed that very 
often there seems to be a saturation point where the effect on the expression level of the gene 
diminishes as the level of transcription factor continues to increase and may reach a plateau or 
even decrease in some cases (see Figure 1). Again, Figure 2 shows the regulation pattern for 
inversely correlated TF and gene. In these plots, positive numbers represent the up-regulation 
of genes (or TF), while negative magnitudes for numbers stand for down-regulation of genes. 
Thus, instead of using simple linear correlation, we measure the correlation using Equation 1 
as our regression curve.  
 
                  ,
y ye y
α = ′  Where α is exponential constant      (1) 
 
In this equation, y’ is dependent on the independent variable y, which is the original 
expression level, and it is multiplied by some exponential constant to generate new values 
(y’). This equation is used commonly in physics to measure half-life to measure radioactive 
decay. The value of parameter α was set to 0.0, 0.25 and 0.5 in different experimental settings. 
This correlation coefficient is more general than simple linear correlation coefficient in that 
by setting α = 0.0, we end up with the simple linear correlation coefficient.  
We calculated Pearson’s Correlation Coefficient, of all pairs of gene and TF for both human 
and mouse datasets using the pre-calculated expression numbers. The values of Pearson’s 
Correlation Coefficient range from -1 to +1. Any value in positive scale indicates increasing 
correlationship, with +1 being perfectly linear correlated and negative values denote the case 
of a negative correlationship. Any value in between in all other cases represents the degree of 
dependency between the variables (i.e. gene and TF pair). The correlation coefficients 
indicate how tightly genes are up-regulated and down-regulated with respect to transcription 
factors. 
2.3  Finding cis-regulatory elements 
To determine the (putative) cis-regulatory elements, we take advantage of the fact that our 
analysis is from tissue-specific microarray of two mammalian species, human and mouse. 
Thus, we can identify orthologous genes between the two species that we speculate to be 
associated with a common TF and analyze their promoter regions using sequence alignment 
to determine possible binding site for the TF [34]. For the human genome, we associate a TF 
as a possible enhancing or repressing regulatory element for a gene if the correlation 
coefficient is greater than 0.3 or less than -0.3, respectively. For the mouse genome, we have 
a more stringent threshold as the correlation coefficients are fairly high. The thresholds for 
positive and negative correlations are set at 0.4 and -0.4, respectively.  
Table 1: List of top ten highly correlated (both positively and negatively) human  genes with 
corresponding transcription factors (here, α = 0.25). 
Transcription Factor  Gene  Correlation  
Coefficient 
SCAND1 ASGR1  0.9460 
NOTCH2 INSIG1  0.9403 
ID1 ITGB1  0.9326 
TCEB3 CTGF  0.9308 
STAT4 S100A8  0.9279 
ZNF134 DSTN  0.9270 Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
RELB ATP2B1  0.9268 
RELB PSMB9  0.9190 
RBPSUH SSR4  0.9173 
SCAND1 F2  0.9151 
ZNF198 TRIO  -0.6928 
PPARBP CENPB  -0.6882 
GABPA C22orf5  -0.6831 
HCLS1 C4A  -0.6803 
ZNF228 EHD1  -0.6800 
TEAD3 ARFGEF2  -0.6705 
PPARBP EPN1  -0.6695 
HCLS1 C4A  -0.6683 
PPARBP BCR  -0.6650 
GABPA NCOR2  -0.6645 
 
Transcriptional regulatory elements are found either upstream or downstream of genes, 
scattered all along thousands of bps in both intergenic and intragenic regions. However, most 
TFBS predictors tend to focus in the proximal promoter region [52] because the difficulty of 
TFBS prediction tends to increase with the size of the region of interest. Besides, increasing 
the region of interest upstream of the transcription start site to more than a few thousand base 
pairs increases the chances of falsely identifying common repeat elements. Thus, we focus on 
the core promoter regions from 500 bps upstream to 200 bps downstream (-500 to +200, total 
700 bps). 
To ensure that our putative TF binding sites are of high quality, we validated them with 
TRANSFAC database [24, 53, 54]. TRANSFAC contains the largest repository for 
experimentally derived TFBS. We also performed further validations of our putative sites 
using P-Match [55]-public and ConSite [56], which combines pattern matching and weight 
matrix approaches thus providing higher accuracy of recognition than each of the methods 
alone. To reduce false-positive validation using P-match, we chose “high quality vertebrate 
matrices only” as our default option. We obtained the report for all pre-selected genes, setting 
cut-off selection for matrices to minimize (1) false-positive, (2) false-negative, and (3) the 
sum of both error rates. Moreover, ConSite [56] is  a user-friendly, web-based tool for finding 
cis-regulatory elements in genomic sequences using high-quality transcription factor models 
and cross-species comparison filtering.  
2.4  Clustering the oncogenes 
In order to explore the collective interactions among TF and oncogenes, we clustered the 
oncogenes with respect to regulating TFs. We constructed an interaction matrix, M, where 
each entry is either one (1) or zero (0) individually based on the correlation coefficients of the 
respective TF-gene pairs. For each possible pair of genes, if the number of one’s along the 
rows exceeds a cut-off, we assign them in the same cluster. These pairs of genes will then be 
used as ‘seeds’ to grow the cluster in a greedy fashion, where new gene is added to the cluster 
if its putative TFBS are found to contain many of the putative TFBS of the genes already in 
the cluster. In each cluster, the correlations between TF and oncogenes are analyzed as a 
group to capture their differential regulation patterns. 
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3  Results and Discussion 
3.1  Correlated genes and transcription factors 
Using Pearson’s Correlation Coefficient (see Methods section), we constructed a list of TF-
gene pairs, either correlated or inversely correlated to each other. Table 1 and Table 2 show 
the top ten most positively and negatively correlated genes and transcription factors for 
human (α = 0.25) and mouse (α = 0.5) in order. The complete list of correlated pairs can be 
obtained from our website [57]. 
We find that many of the TF-gene pairs fit the non-linear function better, especially for the 
human genome. Using a threshold of +0.8 on the correlation coefficients, we find that the 
non-linear function seems to better depict the possible relationship between the TFs and 
genes, especially for the human genome. In our dataset for human, we have 1,114,432 
possible TF-gene pairs. Of them, the number of correlated pairs are 171 (topmost 0.015%), 
372 (0.033%) and 253 (0.023%) for α = 0.0 (linear), α = 0.25 and α = 0.50 respectively. 
Further, we observed that the correlation coefficients of most pairs are greater when α = 0.25 
as opposed to α = 0.0. However, the effect on the mouse genome is not as dramatic, which is 
partly, we believe, due to the already higher linear correlation coefficient. Out of 4,52,076 
possible TF-gene pairs, we found 2,448 (topmost 0.541%), 3,150 (0.70%) and 3,472 (0.77%) 
correlated TF-gene pairs for corresponding α = 0.0 (linear), α = 0.25 and α = 0.50 above +0.8 
correlation coefficient. Therefore, our results concentrate on the correlated TF-gene pairs for 
human at α = 0.25, and for mouse α = 0.5. One of the novelties of our approach is that the 
technique can be scaled up by associating more genomes in the lineage, provided cis-elements 
are spatially conserved.  
In the results for human expression data, we found that SCAND1 (SCAN domain containing 
1) and RELB (v-rel reticuloendotheliosis viral oncogene homolog B) appear more often than 
others. SCAND1 is positively correlated with both ASGR1 (Asialoglycoprotein receptor 1) and 
F2 (Coagulation factor II (thrombin)), while RELB shows the same pattern with ATP2B1 (ATPase, 
Ca++ transporting, plasma membrane 1) and PSMB9 (Proteasome subunit, beta type, 9). In fact, 
the interactions between RELB and PSMB9 are reported in the literature [58]. As shown in 
Figure 1, the regulation pattern among TFs and genes tends to better fit the decay function 
curve than simple linear line, which characterizes our assumption regarding TF-gene 
interaction model. In fact, we observed that the correlation coefficient of most TF-gene pairs 
tend to be higher for the non-linear function regressor than linear regressor.  
Table 2: List of top ten highly correlated (both positively and negatively) mouse genes with 
corresponding transcription factors (here, α = 0.5). 
Transcription Factor  Gene  Correlation  
Coefficient 
LEF1 EPM2A  0.9946 
HOXB1 1700014N06RIK  0.9874 
FOXE1 DFNA5H  0.9825 
RFX1 MESP1  0.9816 
FOXE1 2610207F23RIK  0.9799 
FOXE1 5730403I07RIK  0.9778 
CREB1 2810025M15RIK  0.9750 
E4F1 4930424G05RIK  0.9733 
ZIC1 GTF2E2  0.9720 
ACE 1700027M21RIK  0.9718 
LEF1 REN  -0.9545 
MBP 5930416I19RIK  -0.9501 Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
FOXM1 LOC238771  -0.9494 
FOXD2 8030423J24RIK  -0.9442 
AP1M1 P2RY2  -0.9386 
MBP 2700099C18RIK  -0.9354 
ZIC2 CLDN4  -0.9345 
SIN3B KCNJ11  -0.9339 
HOXB1 9030420J04RIK  -0.9297 
PITX1 MCF2  -0.9167 
  
However, in the cases of anti-correlations, the coefficient numbers of TF-gene pairs are 
relatively low, which is possibly due to intrinsic experimental intricacy in measuring 
negativity in the gene expressions. Among the top short-listed pairs, PPARBP (PPAR binding 
protein), GABPA (GA binding protein transcription factor, alpha subunit 60kDa) and HCLS1 
(Hematopoietic cell-specific Lyn substrate 1) showed up more frequently with corresponding 
down-regulated genes. 
Our analysis of mouse expression data revealed that there are surprisingly strong correlations 
among genes in both directions, with 3,684 pairs having coefficient greater than 0.8 or below 
-0.8 as opposed to 372 in human. We believe that this is probably an artifact of the data. 
FOXE1 (Forkhead box E1) showed up most often in the positively correlated pairs, while 
MBP (Myelin basic protein) is the most frequently occurring in the negative list. Some TFs 
seemed to enhance the expression level of some genes while suppressing others. For example, 
LEF1 (Lymphoid enhancer-binding factor 1) and HOXB1 (Homeo box B1) are included in 
both positive and negative list. 
Table 3: The list of identified binding sites for four TFs. The consensus sequence logo plots for 
available PWM’s in TRANSFAC are shown. Results were validated using both TRANSFAC and 
ConSite. 
For TF E2F5 
 
Genes 
 
 
Factor Name 
Position in 
Human 
sequence 
(strand) 
Position in Mouse 
sequence 
(strand) 
 
Consensus sequence 
EZH2  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
 
533 (+) 
 
494 (+) 
 
TTTGGcgc 
RPA2  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
 
331 (+) 
 
158 (+) 
 
TTTGGcgc 
TYMS  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
 
464 (-) 
 
468 (-) 
 
gcgGGAAA 
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SUPT16H  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
 
559 (-) 
 
3 (-) 
 
ccgCGAAA 
NMI  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
 
553 (+) 
 
626 (+) 
 
TTTCGcgg 
GART  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
 
249 (+) 
 
16 (+) 
Seq found: 
TTTGGTCA   
TTTGGcgc 
MBD4  No Hits 
DDX6  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
316 (+)  468 (+) 
Seq found: 
TTTCCGAG 
 
TTTCGcgg 
PAPOLA  TRANSFAC 
(P-Match): E2F 
 
ConSite : E2F 
 
188 (-)  No match 
 
gcgGGAAA 
Total hits: 8/10 (80%) 
For TF Relb 
 
Genes 
 
 
Factor Name 
Position in 
Human 
sequence 
(strand) 
Position in Mouse 
sequence 
(strand) 
 
Consensus sequence 
GYS1  TRANSFAC 
(P-Match): c-
Rel 
ConSite : 
c-Rel 
 
 
381 (-) 
 
179 (-) 
Seq found: 
GGAAACT 
GGAAAtcccc 
OGDH  TRANSFAC 
(P-Match): c-
Rel 
ConSite : 
c-Rel 
 
 
36 (+) 
 
434 (+) 
Seq found: 
CTGAAACC 
 
 
caagaAAACC 
SLC25A4  TRANSFAC 
(P-Match): c-
Rel 
ConSite : 
c-Rel 
 
 
464 (-) 
 
397 (-) 
Seq found: 
gagCTTCC 
 
tggagCTTCC 
STAR  TRANSFAC 
(P-Match): c-
Rel 
 
370 (+) 
293 (-) 
 
21 (+) 
Seq found: 
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ConSite : 
c-Rel 
 
AAACC 
Ruvbl1  TRANSFAC 
(P-Match): c-
Rel 
ConSite : 
c-Rel 
 
 
53 (+) 
 
No match 
gggccTTTCC 
Sqrdl  TRANSFAC 
(P-Match): c-
Rel 
ConSite : 
c-Rel 
 
 
399 (+) 
 
311 (+) 
Seq found: 
CTTTC 
gggacCTTTC 
Abcd3  TRANSFAC 
(P-Match): c-
Rel 
ConSite : 
c-Rel 
 
 
1 (+) 
 
54 (+) 
Seq found: 
tctTTTCC 
tgtgtTTTCC 
Ngfrap1  No hits  c-Rel   
Map4k5  TRANSFA
C 
(P-Match): 
c-Rel 
ConSite : 
c-Rel 
 
 
93 (-) 
 
142 (-) 
Seq found: 
GGTTTTCAAA 
 
GGTTTgcaaa 
 
Nfia 
TRANSFA
C 
(P-Match): 
c-Rel 
ConSite : 
c-Rel 
 
 
 
621 (+) 
 
 
No match 
 
 
cctccAAACC 
S100A1  TRANSFAC  (P-Match): No hit;    ConSite : c-Rel 
Actr3  TRANSFA
C 
(P-Match): 
c-Rel 
ConSite : 
c-Rel 
 
 
345 (-) 
 
333 (-) 
Seq found: 
GGAAA 
 
GGAAAacccg 
Ap3b1  TRANSFA
C 
(P-Match): 
c-Rel 
ConSite : 
c-Rel 
 
 
178 (+) 
 
No match 
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Btg1  TRANSFA
C 
(P-Match): 
c-Rel 
ConSite : 
c-Rel 
 
 
203 (+) 
 
187 (+) 
 
cggagCTTTC 
Total hits: 12/14 (85.71%) 
For TF Sp3 
 
Genes 
 
 
Factor Name 
Position in 
Human 
sequence 
(strand) 
Position in Mouse 
sequence 
(strand) 
 
Consensus sequence 
CLPTM1  TRANSFAC 
(P-Match): 
YY1 
ConSite : 
Yin-yang 
 
506 (-) 
507 (-) 
Seq found: 
ggaagATGGCggcgg 
 
gagcgggaagATGGCggcgg 
PPARBP  TRANSFAC 
(P-Match): 
YY1 
ConSite : 
No Match 
 
497 (-) 
 
485 (-) 
gttggggaagATGGCggcgg 
ARPC2  TRANSFAC 
(P-Match): 
YY1 
ConSite : 
No Match 
 
432 (-) 
 
443 (-) 
gaagcggaaATGGCgccgc 
AP1M1  TRANSFAC  (P-Match): No hit;    ConSite : Yin-yang 
CIT  TRANSFAC  (P-Match): No hit;    ConSite : Yin-yang 
GABPA  TRANSFAC 
(P-Match): 
YY1 
ConSite : 
No Match 
 
49 (+) 
212 (+) 
 
430 (+) 
Seq found: 
ctccGCCATcttt 
tacccGCCATcgcaatgcat 
cctccGCCATcttttcttcg 
Total hits: 4/6 (66.67%) 
 
For TF STAT4 
 
Genes 
 
 
Factor Name 
Position in 
Human 
sequence 
(strand) 
Position in Mouse 
sequence 
(strand) 
 
Consensus sequence 
ARPC2  No hits 
TMSB10  TRANSFAC 
(P-Match): 
STATx 
ConSite : 
STATx 
 
235 (+) 
 
213 (+) 
Seq found: 
TTCCCg 
 
TTCCCggaa 
Total hits: 1/2 (50%) 
 
We screened out common genes that are co-expressed with these TFs. In order to quantify the 
conservation of regulatory elements along these gene sequences, the core promoter regions 
(see Methods) were fed to P-Match [55] using all three available options for handling false 
discoveries. Basically, the output with option “minimizing false negative” considers merely 
minimal number of base pairs match and calls it a hit. Thus it improves its recall numbers Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
(maximize loose-bound relevance at the cost of precision), with a huge list of cis-element 
candidates. We expect the false-positive rate to be extremely high for the predictions to be 
meaningful. Therefore, we did not discard this option. Among the other options, “minimize 
false positive” tries to find exact (~100%) PWM match and accounts for the most precise TF 
hits. The other option “minimize sum of both error rates” seems to take advantage from the 
best of both worlds (keeping balance on both recall and precision) and evens out high false 
discovery rates. To ensure better quality of our analysis, we considered only the option 
“minimize false positive”, which maximizes the precision values without compromising too 
much with recall values.  We summarize the sample results (precision >= 50%) for both 
human and mouse genomes in Table 3. The results for consulting ConSite are furnished as 
well. The consensus sequences (Logo-plots) for respective TFBS were extracted from TFM-
Explorer [17]. 
Among eight TFs, our prediction performances for four TFs are encouraging while there is no 
highly correlated human pair showed up for the other four TFs. For instance, out of the 10 
human genes that are associated with E2F5 (E2F transcription factor 5), a member of E2F TF 
family, 8 genes (80% hit rate) carry the supposed binding sites. Comparing the sequence 
patterns of binding sites, we can say that almost all of them share the consensus 
‘TTTSSCGC’ where S could be a C or G. Out of these 8 human genes that are hit, 7 of the 
mouse orthologs also have the consensus sequence ‘TTTSSCGC’ in the promoter region.  
As per validation, we reviewed biological literature and found that there is a strong 
association between E2F5 and EZH2 (enhancer of zeste homolog 2), which appears in our 
result for binding site predictions. The E2F transcription factors, considered to be oncogenes 
[59], are key regulators of cell cycle progression [60], apoptosis and DNA damage response 
[61]. Loss of E2F functionality results in acute developmental effects [62]. It is also 
evidenced that pRB-E2F pathway (The retinoblastoma protein-E2F) strongly regulates the 
expressions of Polycomb group genes (PcG), one of which is EZH2 [63, 64]. Again, EZH2 is 
downstream of the pRB–E2F pathway and it is up-regulated during the cell proliferation and 
down-regulated during the cell differentiation phases [65]. 
Likewise, for the 14 human genes correlated with TF RELB, we have found 12 genes have the 
consensus sequence for RELB binding which achieve a hit rate of (85.71%). Among these 12 
human genes, the mouse orthologs of 10 genes also contain some consensus sequence for 
RELB binding. Here, we found “TTTCC”  as sense (+), or “GGAAA” as anti-sense (-) 
complementary, to be common motif with a number of out of pattern nucleotides around. 
Similarly, the precision rate for sp3 (Sp3 transcription factor) is 66.67% (4 hits out of 6 genes) 
and for STAT4 (signal transducer and activator of transcription 4) is 50% (1 hit from 2 genes). 
For  sp3, listed genes have cis-elements containing motif “GCCAT”  as sense (+), or 
“ATGGC” as anti-sense (-) counterpart. We believe that the hit rates for the rest are trivial 
due to the lack of sufficient correlated genes showing up. 
3.2 Analyses  of  oncogenes 
We selected a number of proto-oncogenes that are linked to various types of leukemia (AML, 
ALL, CML etc.) and breast cancer to illustrate our analyses. As discussed below, some 
correlated TF-gene pairs have been shown to bear regulatory relationship (Table 4 and Table 
5).  Moreover, some prospective candidates in our results actually comply with supporting 
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3.2.1 Leukemia  genes 
The  BCR  (Breakpoint cluster region) contains the Chromosome 22 breakpoint for the 
translocation that produces Philadelphia Chromosome [66], which is very often found in 
patients with CML (Chronic Myelogenous  Leukemia). The translocation occurs between 
BCR (in Chromosome 22) and ABL (v-abl Abelson murine leukemia viral oncogene homolog 
in Chromosome 9q34), and this reciprocal translocation creates a tyrosine kinase, which is 
self-activated. Eventually this complex speeds up cell division, inhibits DNA repair, and 
causes genomic instability and blast effect in CML. Our analysis shows that BCR is up-
regulated with NR2F6 and PCOLN3, which complements previous studies [67, 68]. Our other 
candidates are CENPB (Centromere protein B) and NCOR2 (Nuclear receptor co-repressor 2) 
as positively correlated transcription factors and SP3 (Sp3 transcription factor) as negatively 
correlated transcription factors. 
One of the well-recognized oncogenes for AML (Acute Myelogenous Leukemia) is MLL 
(myeloid/lymphoid or mixed-lineage leukemia) [69-72]. In our analysis, we found MDM2 
(transformed 3T3 cell double minute 2, p53 binding protein), which is a potential target of 
tumor suppressor protein p53, to be up-regulated with MLL. Over-expression of MDM2 may 
cause excessive inactivation of tumor protein p53, deteriorating its tumor suppressor function 
[73, 74]. 
The DEK (DEK oncogene) gene produces a fusion with the CAN protein in a subtype of AML 
patients [75]. We found HMGB1 (high-mobility group box 1) in our analysis, and it was also 
reported in the literature as a gene which controls the binding behavior of DEK [76].  Another 
transcription factor correlated with DEK is sp3 (Sp3 transcription factor) [77]. 
We also furnished correlated transcription factors for LMO2 (LIM domain only 2), ETV6 (ets 
variant gene 6), RUNX1 (runt-related transcription factor 1, also called AML1), BTG1 (B-cell 
translocation gene 1, anti-proliferative) FCGR2B (Fc fragment of IgG, low affinity IIb, 
receptor, Loc. 1q23), LCK (lymphocyte-specific protein tyrosine kinase, Loc. 1p34.3), which 
are relevant to leukemia. 
Table 4: The list of transcription factors highly correlated to leukemia genes 
Gene Transcription 
Factor 
Correlation 
Coefficient 
Gene Transcription 
Factor 
Correlation 
Coefficient 
ZMIZ2  0.6532  PLEK  0.8295 
DPP7  0.6446  SP110  0.7726 
EPN1  0.5957  DOCK2  0.7502 
  GRINA  0.5837    TMSB4Y  0.7468 
BCR HMOX2  0.5641  BTG1 CD53 0.7301 
GABPA  -0.6634  GCSH  -0.5434 
PPARBP  -0.6360  BMPR1A  -0.5015 
TFAM  -0.6298  LRP6  -0.4736 
MAPK8IP3  -0.6247  PFN2  -0.4682 
  STAG2  -0.6236    ZDHHC7  -0.4587 
ADAMTS1  0.6352  RAC2  0.9286 
YWHAZ  0.6003  TRB@  0.9107 
IFI16  0.5976  LIMD2  0.9086 
  KLF4  0.5855    CD3D  0.8960 
MYC TUBA3 0.5813  LCK DOCK2  0.8875 
MYO10  -0.5300  NCKAP1  -0.6768 
GCSH  -0.5190  LRP6  -0.6414 
XPO4  -0.5034  RBM9  -0.6216 
 
DDAH1  -0.4945 
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MAPRE3  -0.4925  BMPR1A  -0.6041 
HMGB1  0.7934  FCGR2C  0.8553 
STAG2  0.7594  FCER1G  0.8087 
GDI2  0.7302  AIF1  0.7920 
  PSMA4  0.7113    HCLS1  0.7877 
DEK PPARBP  0.7073  FCGR2B HEM1  0.7851 
WWP2  -0.5237  TOM1L1  -0.5286 
ATP6V0A1  -0.5220  MTX2  -0.4815 
QDPR  -0.5002  PFN2  -0.4796 
EPN1  -0.4984  HDLBP  -0.4759 
  GRINA  -0.4897    H1F0  -0.4735 
DNCH1  0.6081  SSH2  0.5702 
AKAP11  0.5910  MSL3L1  0.5087 
MPHOSPH1  0.5363  MAP4K4  0.5024 
  DNCH1  0.5282    BRD4  0.4790 
MLL TERF2  0.4534  RUNX1 GMFG  0.4715 
PRDX6  -0.4987  CRYL1  -0.5235 
KIAA0152  -0.4449  FLJ20315  -0.4564 
IL1R1  -0.4410  GJA7  -0.4508 
TM9SF1  -0.4235  AIG1  -0.4493 
  MID1  -0.4225    CRYZ  -0.4377 
PTH  0.5959  INPP4B  0.6494 
GATA3  0.5737  MAP3K8  0.6462 
SYK  0.5693  CHDH  0.6392 
  PVALB  0.5657    SWAP70  0.6307 
ETV6 PTN 0.5468  LMO2 PTTG1 0.6187 
KIAA0934  -0.4292  NBEA  -0.4997 
PMP22  -0.4246  CDC42BPA  -0.4722 
FBN1  -0.4151  MXI1  -0.4624 
TCF8  -0.4138  XK  -0.4319 
  NT5E  -0.4064    EXTL2  -0.4251 
 
Our analyses on oncogenes provide some supporting evidence for the correlations between 
transcription factors and corresponding genes. Most often, the findings are consistent with 
what we found in biological literature surveys. Also we find a number of significant 
candidates that may be quite relevant to cancer studies. For example, NR2F6, which is a 
nuclear receptor, is positively correlated with breast cancer gene (ErbB2) and one of the 
leukemia genes (BCR), while it is inversely correlated with other leukemia gene (DEK). 
Collectively, we may analyze the inter-relationships among leukemia genes and correlated 
transcription factors (see Table 6). Similarly, we discovered identical expression pattern 
among BTG1, FCGR2B and LCK genes (see Table 7). In fact, FCGR2B and LCK show up in 
the B-Cell Receptor Signaling Pathway and the T-Cell Receptor Signaling Pathway 
respectively, which seems to be the reason for this concurrence. 
 
Table 5: The list of transcription factors correlated to breast cancer genes 
Gene  Transcription Factor  Correlation Coefficient 
FOXM1  0.4913 
HMGA1  0.5195 
HHEX  0.4388 
MCM5  0.4048 
  GMEB1  0.395 Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
BRCA1 PTTG1  0.3839 
E2F1  0.3816 
NFIB  -0.4069 
FOSB  -0.2364 
EGR1  -0.2075 
  TBX3  -0.1882 
LPIN1  0.7520 
SPINT1  0.6570 
MKNK2  0.6365 
DDR1  0.6153 
NR2F6  0.4288 
 
MEF2C  -0.5445 
ErbB2 NIN  -0.52263 
MBNL1  -0.52012 
SSBP2  -0.51904 
 
ZFP91  -0.4626 
3.2.2  Breast cancer genes 
Unlike leukemia oncogenes, we applied our analysis on two well-known breast cancer genes, 
namely BRCA1 and ErbB2. Because of small number of genes, clustering is not feasible to 
discover the interactions. However, we found some associations among these genes, which 
are backed by literature. 
Certain mutations of BRCA1  (Breast Cancer 1, early onset) cause approximately 40% of 
inherited breast cancers and more than 80% of inherited breast and ovarian cancers [78-89]. 
Our analysis reveals that FOXM1, E2F1, PTTG1, HMGA1, GMEB1, MCM5 and HHEX 
transaction factor genes are positively correlated to the expression of BRCA1, while 
expressions of NFIB, EGR1, FOSB, and TBX3 appear to be inversely correlated to that of 
BRCA1. 
Table 6: Association analysis of BCR, and DEK with transcription factors in terms of regulation 
pattern 
TF  BCR DEK 
NR2F6  +0.4302 -0.3505 
NCOR2  +0.4343 -0.3916 
ZNF74  +0.4504 -0.2813 
PCOLN3  +0.3442 -0.2912 
NR1D1  +0.3491 -0.2866 
HMX1  +0.4477 -0.4396 
HMGB1  -0.5228 +0.7934 
ATF1  -0.5145 +0.5373 
SP3  -0.5664 +0.6177 
TFAM  -0.6298 +0.6165 
GABPA  -0.6634 +0.6907 
NPM1  -0.6390 +0.6731 
ELF1  -0.4434 +0.6473 
 
FOXM1 (Forkhead box M1) has been found to be responsible for epithelial ovarian tumors 
correlated with malignancy [90] and it is over-expressed in transcriptional regulations. There 
is much evidence that E2F1 (E2F transcription factor 1) is related to control of BRCA1. Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
Hennighausen [91] simulated the mouse model of breast cancer and established the presence 
of E2F1 in cancer-causing. Again, the E2F family plays a crucial role in the control of cell 
cycle and action of tumor suppressor proteins and is also a target of the transforming proteins 
of small DNA tumor viruses. So, E2F-responsive promoters appear to be more active in 
tumor cells relative to normal cells. Recently, pharmacogenomics studies showed that murine-
derived anticancer agents, namely YondelisTM (Trabectedin, ET-743) [92], target markers 
like  PTTG1 (pituitary tumor-transforming 1) and HHEX (Homeobox, hematopoietically 
expressed). Baldassarre et. al. [93] found strong interactions between HMGA1 (high mobility 
group AT-hook 1) and BRCA1 in sporadic breast carcinoma. In fact, transcriptional binding 
sites of BRCA1 are edged upstream and downstream by AT-rich sequences which represent 
preferred binding sites for HMGA1. Moreover, Wan et. al. [67] reported the association of 
GMEB1 (Glucocorticoid modulatory element binding protein 1 and MCM5 (Minichromosome 
maintenance deficient 5, cell division cycle 46). In negative counterpart, that EGR1 (Early 
growth response 1) inversely act towards the BRCA1 expression is evidenced by Cooper [94] 
and Robson [95]. Substantial facts of TBX3 (T-box 3,) being correlated with BRCA1 has been 
also reported [96]. 
Table 7: Association analysis of BTG1, FCGR2B and LCK with transcription factors in terms of 
regulation pattern. 
TF  BTG1 FCGR2B  LCK 
ETS1  +0.7230 +0.6618 +0.8468 
SP110  +0.7726 +0.6827 +0.7928 
SP140  +0.6696 +0.5598 +0.7821 
HCLS1  +0.7297 +0.7877 +0.8101 
TNFAIP3  +0.5729 +0.6513 +0.5316 
IFI16  +0.5869 +0.6094 +0.5391 
TRIM22  +0.5860 +0.6056 +0.6201 
ARNT2  -0.6084 -0.2948 -0.2755 
ARNTL  +0.6701 +0.7616 +0.5599 
ELF1  +0.6083 +0.5397 +0.7234 
RBM9  -0.3579 -0.3460 -0.6216 
 
ErbB2/HER2 (HER2/neu, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/ 
glioblastoma derived oncogene homolog) [97-101] is a proto-oncogene located at 17q11.2-
q12, 17q21.1 and belongs to the epithelial growth factor receptor (EGFR). It codes for a cell 
membrane surface-bound receptor tyrosine kinase that is expressed abundantly by 
transcriptional regulation in approximately 20%-40% of breast cancer and it is notably treated 
as a target gene for therapy. Often it plays a vital role in cell growth, differentiation and 
metastasis. We found several TFs, like NR2F6, RORC, TEAD3, IRX3, SOX13, PCOLN3, as 
positively expressed, and MEF2C, ZFP91, MEF2C, ZFP1 as negatively correlated with 
ErbB2. NR2F6 (Nuclear receptor subfamily 2, group F, member 6) was commented to be 
coupled with the expression of HER2 [68]. Also in-vitro studies showed that he 
phosphorylation of the exogenous MEF2C (Myocyte enhancer factor 2C) is dramatically 
increased by epithelial growth factor (EGF) and thus it refers to its association with controls 
of ErbB2 expression [102]. 
4 Conclusions 
By analyzing tissue-specific gene expression profiles of human and mouse, we produced a list 
of putative trans-elements and their associated genes. We demonstrated that the use of decay 
function instead of linear function as regressor is more appropriate for capturing possible Journal of Integrative Bioinformatics 2007                                                    http://journal.imbio.de/ 
regulatory relationship. As a measure of the quality of the predicted trans-elements, we focus 
on the set of transcription factors and genes that share the same gene names in both mouse 
and human data sets. Our analysis of oncogenes provides further assurance of the quality of 
the predicted trans-elements. Note that a highly correlated TF-gene pair that is not currently 
known to bear regulatory relationship may still be a correct trans-element prediction that is 
yet to be validated. ChIP-chip experiment is designed to test protein-DNA binding, where the 
binding of a transcription factor to a promoter region of a gene provides necessary but not 
sufficient evidence for transcription regulation. As a possible further step to confirm the 
regulatory relationship, the TF-gene pairs and their correlation coefficients constructed here 
may serve as a source of reference for additional confirmation of ChIP-chip results.  
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